Aminex Therapeutics

Kenmore, WA · Founded 2009 · Privately Held (backing)

Operator of a drug development company intended to focus on advancing novel immunotherapy for cancer treatment and cure. Aminex Therapeutics is based in Kenmore, WA and was founded in 2009. It was valued at $105 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $47.6 million across 6 recorded rounds; the latest was a $15.1 million early-stage round in Oct 2022.

PMV mark · valuation
$105.1M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$47.6M
Last round
Early Stage VC
Oct 2022

Who backs Aminex Therapeutics?

1 investors
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Aminex Therapeutics investors

1 investor is on record for Aminex Therapeutics, including United States Department of the Treasury. The early-stage round in Oct 2022 drew 162 investors.

Free account
More of Aminex Therapeutics with a free account
  • ·Watch Aminex Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 1 firms already write checks for companies like Aminex Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View